Tci Wealth Advisors, Inc. Astrazeneca PLC Transaction History

Tci Wealth Advisors, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$63.15 - $71.6 $126 - $143	2 Added 0.11%	1,815 $125,000
Q4 2022 Feb 06, 2023	BUY	$54.21 - $70.44 $66,027 - $85,795	1,218 Added 204.71%	1,813 $122,000
Q3 2022 Nov 08, 2022	BUY	$53.02 - $135.75 $53 - $135	1 Added 0.17%	595 $33,000
Q2 2022 Jul 19, 2022	SELL	$59.26 - $71.14 $948 - $1,138	-16 Reduced 2.62%	594 $39,000
Q1 2022 Apr 29, 2022	SELL	$55.72 - $67.12 $10,698 - $12,887	-192 Reduced 23.94%	610 $40,000
Q4 2021 Jan 24, 2022	BUY	$54.02 - $63.83 $8,481 - $10,021	157 Added 24.34%	802 $47,000
Q3 2021 Oct 29, 2021	BUY	$55.56 - $60.79 $5,889 - $6,443	106 Added 19.67%	645 $39,000
Q1 2021 Apr 29, 2021	SELL	$47.16 - $54.44 $28,767 - $33,208	-610 Reduced 53.09%	539 $27,000
Q4 2020 Jan 21, 2021	BUY	$48.52 - $58.02 $46,676 - $55,815	962 Added 514.44%	1,149 $57,000
Q3 2020 Oct 20, 2020	SELL	$53.07 - $61.1 $10,242 - $11,792	-193 Reduced 50.79%	187 $10,000
Q2 2020 Jul 20, 2020	BUY	$43.1 - $55.31 $16,378 - $21,017	380 New	380 $20,000
Q1 2020 Apr 14, 2020	SELL	$37.79 - $51.33 $3,287 - $4,465	-87 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$42.46 - $50.46 $3,694 - $4,390	87 New	87 $4,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.